HomeMRSN • NASDAQ
add
Mersana Therapeutics Inc
Previous close
$2.55
Day range
$2.45 - $2.65
Year range
$1.15 - $6.28
Market cap
315.27M USD
Avg Volume
821.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 2.29M | -78.48% |
Operating expense | 10.50M | -42.25% |
Net income | -24.27M | 55.31% |
Net profit margin | -1.06K | -107.63% |
Earnings per share | -0.20 | 57.45% |
EBITDA | -25.05M | 55.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 162.74M | -43.21% |
Total assets | 179.13M | -42.40% |
Total liabilities | 170.70M | -22.83% |
Total equity | 8.43M | — |
Shares outstanding | 122.68M | — |
Price to book | 36.43 | — |
Return on assets | -33.71% | — |
Return on capital | -123.50% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -24.27M | 55.31% |
Cash from operations | -21.86M | 64.66% |
Cash from investing | 5.51M | 201.38% |
Cash from financing | 153.00K | -99.79% |
Net change in cash | -16.19M | -374.05% |
Free cash flow | -7.98M | 80.35% |
About
Founded
2001
Website
Employees
123
